Polaris Quantum Biotech (POLARISqb)

PolarisQB is utilizing Quantum Computing, Artificial Intelligence, Machine Learning and Personalized Medicine to Revolutionize Drug Design. By compressing the lead time for pre-clinical drug candidates from 5 years to 4 months, we will produce up to 100 drug blueprints per year, enabling real time adaptability within the precision medicine market. Using these methodologies, Polaris will build an IP portfolio of drug assets to license, sell, or develop internally.